What is the ticker symbol for ImmuCell?

ImmuCell trades under the ticker ICCC on NASDAQ.

What sector does ImmuCell operate in?

ImmuCell is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ICCC in a portfolio?

PortView shows ICCC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

ImmuCell (ICCC) Stock Analysis

NASDAQHealthcareBiotechnology

$9.95+0.30%

1-year price historyRange $4.56 – $11.72

52-week range$9.95

$4.52$12.10

What ImmuCell does

ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which specific udder quarter may be affected by mastitis. Its Dual-Force First Defense product, incorporating a whey protein concentrate, caters to the nutritional and animal feed supplement industries. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. The company primarily distributes its products through a network of animal health distributors. ImmuCell Corporation was established in 1982 and is based in Portland, Maine.

Key metrics

Market cap

$90.02M

P/E (TTM)

-165.83

EPS (TTM)

$-0.06

Beta

0.57

Dividend yield

0.00%

Revenue / share

$3.38

50-day avg

$10.57

200-day avg

$7.94

52-week high

$12.10

52-week low

$4.52

CEO

F. Olivier Te Boekhorst

ETFs linked to ICCC

Broad-market and Healthcare sector ETFs an investor holding ImmuCell is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ICCC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ICCC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for ImmuCell?: ImmuCell trades under the ticker ICCC on NASDAQ.
Which exchange is ICCC listed on?: ICCC is listed on NASDAQ.
What sector does ImmuCell operate in?: ImmuCell is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ICCC in a portfolio?: PortView shows ICCC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.